N,N’-bis[2,6-di(propan-2-yl)phenyl]methanediimine | CAS:2162-74-5

We serve N,N’-bis[2,6-di(propan-2-yl)phenyl]methanediimine CAS:2162-74-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N,N'-bis[2,6-di(propan-2-yl)phenyl]methanediimine

Synonyms：
Staboxol 1
Bis(2,6-diisopropylphenyl)carbodiimide
DipN=C=NDip
Carbodiimide,bis(2,6-diisopropylphenyl)-(7CI,8CI)
N,N'-bis(2,6-diisopropylphenyl) carbodiimide
N,N'-bis[2,6-di(propan-2-yl)phenyl]carbodiimide
2,2',6,6'-Tetraisopropyldiphenylcarbodiimide
N,N'-Methanediylidenebis(2,6-diisopropylaniline)
Carbo D
EINECS 218-487-5
N,N'-Methanetetraylbis(2,6-bis(1-methylethyl)benzenamine)
di-(2,6-di-isopropylphenyl)-carbodiimide
DiipNCNDiip
 
Molecular Formula:  C25H34N2
Molecular weight：362.55100
 
Appearance and properties: white to off-white crystalline powder
Density: 0.95 g/cm3
Boiling point: 477.7ºC at 760 mmHg
Melting point: 49 – 51ºC
Flash point: 235.6ºC
Refractive index: 1.528

Items of Analysis Standard of Analysis Test Results
Appearance White crystal Conform
Melting point ≥49℃ 50.2℃－51.1℃
Purity ≥99.0% 99.8%
Lose on drying ≤0.5% 0.2%
Conclusion Conforms to Factory Standard
 



Contact us for information like N,N’-bis[2,6-di(propan-2-yl)phenyl]methanediimine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DiipNCNDiip physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N’-bis(2,6-diisopropylphenyl) carbodiimide Use and application,EINECS 218-487-5 technical grade,usp/ep/jp grade.


Related News: The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15.2-decanoyl-5-phenylcarbamoylimino-2H-[1,2,3]thiadiazole manufacturer This is how an API becomes a medicine. 7-Methoxy-4-(4-methyl-piperidin-1-ylmethyl)-3,4-dihydro-2H-benzo[b]oxepin-5-one supplier Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.5-phenyl-1H-pyrrolo[1,2-b][1,2,5]triazepin-2(3H)-one vendor A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018. Combining its core technological advantages such as ammonia oxidation, phosgenation, and fluorination, the company actively enters the field of fine and functional chemicals, and expands its focus to include polymer additives, replacement of phenolic polymer material monomers, and coating preservatives.